Cyclacel Pharma (CYCC) Reports Q4 Loss of $0.17/Share

Cyclacel Pharma (NASDAQ: CYCC) reported Q4 EPS of ($0.17), versus ($0.14) reported last year.

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital
• United Community Banks sells equipment finance unit for $1.9 billion